Buprenorphine injection in Melbourne, Australia - An update

Abstract

Objective. To investigate the prevalence and associations of buprenorphine injection among a field-recruited cohort of injecting drug users. Design. Cross-sectional data from a prospective longitudinal cohort. Setting. Metropolitan Melbourne, Australia. Subjects. Current injecting drug users (IDUs). Main Outcome Measures. Prevalence of buprenorphine injection, associations with location, buprenorphine as prescribed pharmacotherapy, markers of hepatitis C virus (HCV) exposure and risk behaviours for HCV. Results. More than 10% of our 316 participants reported buprenorphine as the drug they had most often injected, and 32% had injected buprenorphine at least once in the 3 months prior to inter..